| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lauren Hoo. Social Factors and Animal Models of Cannabis Use. International review of neurobiology. vol 140. 2019-03-21. PMID:30193704. |
psychoactive cannabinoids, or the pharmacologically active compounds within cannabis, are responsible for producing the infamous "high" sensation, characterized by feelings of euphoria and relaxation, though can also provoke hallucinations, paranoia and anxiety. |
2019-03-21 |
2023-08-13 |
Not clear |
| Tatjana Gazibara, Milica Prpic, Gorica Maric, Tatjana Pekmezovic, Darija Kisic-Tepavcevi. Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult Population. Journal of psychoactive drugs. vol 49. issue 3. 2018-04-25. PMID:28632077. |
a total of 42% answered correctly that adverse effects of cannabis were hallucinations and dizziness. |
2018-04-25 |
2023-08-13 |
human |
| Chiara Galletti, Enrico Paolini, Alfonso Tortorella, Michael T Compto. Auditory and non-auditory hallucinations in first-episode psychosis: Differential associations with diverse clinical features. Psychiatry research. vol 254. 2018-02-05. PMID:28482196. |
however, the two hallucination domains had different associations with grandiose/religious, paranoid, and somatic delusions; sans score; childhood violence exposure; cannabis use disorders; and cocaine/other drug use disorders. |
2018-02-05 |
2023-08-13 |
Not clear |
| N Paleiron, M André, M Durand, C Tromeur, C Giacardi, F Grassin, U Vinsonnea. [Cannabis "bong": A frequent, original and dangerous way of consumption]. Revue de pneumologie clinique. vol 72. issue 3. 2017-05-01. PMID:27113618. |
the cannabis intoxication can then be associated with disorders of sensory functions, the type of distortion of perceptions or hallucinations, often accompanied by intense anxiety. |
2017-05-01 |
2023-08-13 |
Not clear |
| Steven Marwaha, Andrew Thompson, Paul Bebbington, Swaran P Singh, Daniel Freeman, Catherine Winsper, Matthew R Broom. Adult attention deficit hyperactivity symptoms and psychosis: Epidemiological evidence from a population survey in England. Psychiatry research. vol 229. issue 1-2. 2016-04-05. PMID:26235475. |
the link between higher adhd symptoms and psychosis, paranoia and auditory hallucinations was significantly mediated by dysphoric mood, but not by use of amphetamine, cocaine or cannabis. |
2016-04-05 |
2023-08-13 |
Not clear |
| Anna Mané, Miguel Fernández-Expósito, Daniel Bergé, Laura Gómez-Pérez, Agnés Sabaté, Alba Toll, Laura Diaz, Cristobal Diez-Aja, Victor Pere. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables. Psychiatry research. vol 229. issue 1-2. 2016-04-05. PMID:26235479. |
the distinguishing reasons to use cannabis for patients with first-episode psychosis with respect to non-psychotic users were to arrange their thoughts and deal with hallucinations and suspiciousness. |
2016-04-05 |
2023-08-13 |
Not clear |
| U Bonnet, H Mahle. [Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard]. Fortschritte der Neurologie-Psychiatrie. vol 83. issue 4. 2016-01-11. PMID:25893495. |
when inhaled or ingested, besides intoxication symptoms, as they occur with heavy cannabis use (e. g., tachycardia, myocardial infarction, confusion, hallucinations, panic attacks, and paranoia), harmful effects (severe agitation, coma, catatonic stupor, hypertension, cardiac arrhythmia, dyspnoea, seizures, myoclonus, rhabdomyolysis, hyperthermia, diaphoresis, acute kidney injury, vomiting, headache, and hypokalemia) arise, which are mostly unusual about cannabis use. |
2016-01-11 |
2023-08-13 |
Not clear |
| Sania Shakoor, Helena M S Zavos, Philip McGuire, Alastair G Cardno, Daniel Freeman, Angelica Ronal. Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors. Psychiatry research. vol 227. issue 2-3. 2015-12-14. PMID:25912376. |
environmental influences explained all of the covariation between cannabis use and paranoia, cognitive disorganization and parent-rated negative symptoms (bivariate common environment=69-100%, bivariate unique environment=28-31%), whilst the relationship between cannabis use and hallucinations indicated familial influences. |
2015-12-14 |
2023-08-13 |
Not clear |
| Miguel Ruiz-Veguilla, María Luisa Barrigón, Laureano Hernández, José Luis Rubio, Manuel Gurpegui, Fernando Sarramea, Jorge Cervilla, Blanca Gutiérrez, Anthony James, Maite Ferri. Dose-response effect between cannabis use and psychosis liability in a non-clinical population: evidence from a snowball sample. Journal of psychiatric research. vol 47. issue 8. 2014-01-23. PMID:23684550. |
daily cannabis use appeared to exert a dose-response effect on first-rank symptoms, mania symptoms and auditory hallucinations, even after adjusting for sex, age, other drug use, social exclusion and age at onset of cannabis use. |
2014-01-23 |
2023-08-12 |
human |
| Vikhyat S Bebarta, Sasha Ramirez, Shawn M Varne. Spice: a new "legal" herbal mixture abused by young active duty military personnel. Substance abuse. vol 33. issue 2. 2012-08-21. PMID:22489593. |
expected effects are similar to cannabis, but may include more paranoia and hallucinations, and may differ for each brand. |
2012-08-21 |
2023-08-12 |
Not clear |
| Jan Dirk Blom, Hafize Eker, Hillal Basalan, Youssef Aouaj, Hans Wijbrand Hoe. [Hallucinations attributed to djinns]. Nederlands tijdschrift voor geneeskunde. vol 154. 2010-02-25. PMID:20132570. |
the second patient was a 25-year-old unemployed man, who had auditory hallucinations, delusions, behavioural problems, and alcohol and cannabis abuse. |
2010-02-25 |
2023-08-12 |
Not clear |
| Leanne Hides, Dan I Lubman, Joe Buckby, Hok Pan Yuen, Elizabeth Cosgrave, Kathryn Baker, Alison R Yun. The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophrenia research. vol 112. issue 1-3. 2009-09-03. PMID:19428219. |
lifetime cannabis use and the frequency of cannabis use in the last year (recent use) were associated with ples, primarily the experience of auditory and visual hallucinations (perceptual abnormalities). |
2009-09-03 |
2023-08-12 |
human |
| James Scott, Graham Martin, William Bor, Michael Sawyer, Jennifer Clark, John McGrat. The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophrenia research. vol 107. issue 2-3. 2009-04-20. PMID:19046858. |
adolescents completed self-report questionnaires with two questions relating to hallucinations and questions pertaining to depressive symptoms and cannabis use. |
2009-04-20 |
2023-08-12 |
human |
| James Scott, Graham Martin, William Bor, Michael Sawyer, Jennifer Clark, John McGrat. The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophrenia research. vol 107. issue 2-3. 2009-04-20. PMID:19046858. |
hallucinations were associated with depressive disorder (or 2.70; 95% ci 1.16, 6.28) and were more prevalent in those adolescents who had smoked cannabis more than twice in the month prior to the survey (or 3.27; 95% ci 1.76, 6.08). |
2009-04-20 |
2023-08-12 |
human |
| Amy Cochems, Patrick Harding, Laura Liddicoa. Dextromethorphan in Wisconsin drivers. Journal of analytical toxicology. vol 31. issue 4. 2007-07-25. PMID:17555648. |
dextromethorphan can produce psychoactive effects similar to that of marijuana, and higher doses will produce dissociative effects, including sensory enhancement and hallucinations. |
2007-07-25 |
2023-08-12 |
Not clear |
| Caroline Dubertret, Isabelle Bidard, Jean Adès, Philip Gorwoo. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16806837. |
the strong association between cannabis abuse and fewer negative symptoms in schizophrenia was thus replicated in this sample, but once co-morbid addictive disorders had been controlled no influence of cannabis abuse on hallucinations was detected. |
2006-12-20 |
2023-08-12 |
human |
| Avshalom Caspi, Terrie E Moffitt, Mary Cannon, Joseph McClay, Robin Murray, HonaLee Harrington, Alan Taylor, Louise Arseneault, Ben Williams, Antony Braithwaite, Richie Poulton, Ian W Crai. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological psychiatry. vol 57. issue 10. 2005-06-08. PMID:15866551. |
recent evidence documents that cannabis use by young people is a modest statistical risk factor for psychotic symptoms in adulthood, such as hallucinations and delusions, as well as clinically significant schizophrenia. |
2005-06-08 |
2023-08-12 |
Not clear |
| b' Amira Redzi\\xc4\\x87, Ifeta Licanin, Jasminka Hadzihalilovi\\xc4\\x8. Some aspects of the psychoactive substances abuse in adolescents. Bosnian journal of basic medical sciences. vol 4. issue 2. 2005-01-26. PMID:15629025.' |
cannabis is a plant whose consumption causes hallucinations soon after it has been inhaled. |
2005-01-26 |
2023-08-12 |
Not clear |
| Paul C Bressloff, Jack D Cowan, Martin Golubitsky, Peter J Thomas, Matthew C Wiene. What geometric visual hallucinations tell us about the visual cortex. Neural computation. vol 14. issue 3. 2002-03-13. PMID:11860679. |
many observers see geometric visual hallucinations after taking hallucinogens such as lsd, cannabis, mescaline or psilocybin; on viewing bright flickering lights; on waking up or falling asleep; in "near-death" experiences; and in many other syndromes. |
2002-03-13 |
2023-08-12 |
Not clear |
| A Y Tien, J C Anthon. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. The Journal of nervous and mental disease. vol 178. issue 8. 1990-09-10. PMID:2380692. |
after control for sociodemographic factors and preexisting psychiatric conditions, the risk for onset of self-reported delusions or hallucinations was observed to be greater for daily users of marijuana or cocaine and for users of anxiolytics or sympathomimetics compared with nonusers. |
1990-09-10 |
2023-08-11 |
Not clear |